Exact Mass: 511.0104

Exact Mass Matches: 511.0104

Found 22 metabolites which its exact mass value is equals to given mass value 511.0104, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

ppads

Pyridoxalphosphate-6-azophenyl-2,4-disulfonic acid

C14H14N3O12PS2 (510.9757)


D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

Cefmenoxime

(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N9O5S3 (511.0515)


Cefmenoxime is only found in individuals that have used or taken this drug. It is a third-generation cephalosporin antibiotic. [Wikipedia]The bactericidal activity of cefmenoxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefmenoxime is stable in the presence of a variety of b-lactamases, including penicillinases and some cephalosporinases. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Ppads

4-(2-{4-formyl-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]pyridin-2-yl}diazen-1-yl)benzene-1,3-disulfonic acid

C14H14N3O12PS2 (510.9757)


D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   
   
   
   

Cefmenoxima

(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N9O5S3 (511.0515)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

4-(Heptadecafluorooctyl)aniline

4-(Heptadecafluorooctyl)aniline

C14H6F17N (511.0229)


   

2-[Methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl acrylate

2-[Methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl acrylate

C12H10F13NO4S (511.0123)


   

N-[2-[(2,6-dibromo-4-nitrophenyl)azo]-5-(diethylamino)phenyl]acetamide

N-[2-[(2,6-dibromo-4-nitrophenyl)azo]-5-(diethylamino)phenyl]acetamide

C18H19Br2N5O3 (510.9855)


   

3-(HEPTADECAFLUOROOCTYL)ANILINE

3-(HEPTADECAFLUOROOCTYL)ANILINE

C14H6F17N (511.0229)


   
   
   

2-chloro-1-[3-[2-chloro-4-(trifluoromethyl)phenoxy]-4-nitrophenoxy]-4-(trifluoromethyl)benzene

2-chloro-1-[3-[2-chloro-4-(trifluoromethyl)phenoxy]-4-nitrophenoxy]-4-(trifluoromethyl)benzene

C20H9Cl2F6NO4 (510.9813)


   

Chromium,tris(1,1,1-trifluoro-2,4-pentanedionato-kO2,kO4)-

Chromium,tris(1,1,1-trifluoro-2,4-pentanedionato-kO2,kO4)-

C15H12CrF9O6 (510.9895)


   

Cefmenoxime

Cefmenoxime

C16H17N9O5S3 (511.0515)


A third-generation cephalosporin antibiotic, bearing a 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino group at the 7beta-position and a [(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl group at the 3-position. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Ethyl cytidine triphosphate

Ethyl cytidine triphosphate

C11H20N3O14P3 (511.0158)


   

N-[2-(2-chlorophenyl)-5-hydroxy-4-oxo-1-benzopyran-8-yl]-2-(trifluoromethoxy)benzenesulfonamide

N-[2-(2-chlorophenyl)-5-hydroxy-4-oxo-1-benzopyran-8-yl]-2-(trifluoromethoxy)benzenesulfonamide

C22H13ClF3NO6S (511.0104)


   

(2e)-n-{3-[4-(2-aminoethyl)-2,6-dibromophenoxy]propyl}-2-(n-hydroxyimino)-3-phenylpropanimidic acid

(2e)-n-{3-[4-(2-aminoethyl)-2,6-dibromophenoxy]propyl}-2-(n-hydroxyimino)-3-phenylpropanimidic acid

C20H23Br2N3O3 (511.0106)


   

n-{3-[4-(2-aminoethyl)-2,6-dibromophenoxy]propyl}-2-(n-hydroxyimino)-3-phenylpropanamide

n-{3-[4-(2-aminoethyl)-2,6-dibromophenoxy]propyl}-2-(n-hydroxyimino)-3-phenylpropanamide

C20H23Br2N3O3 (511.0106)


   

(2e)-n-{2-[4-(3-aminopropoxy)-3,5-dibromophenyl]ethyl}-2-(n-hydroxyimino)-3-phenylpropanimidic acid

(2e)-n-{2-[4-(3-aminopropoxy)-3,5-dibromophenyl]ethyl}-2-(n-hydroxyimino)-3-phenylpropanimidic acid

C20H23Br2N3O3 (511.0106)


   

n-{2-[4-(3-aminopropoxy)-3,5-dibromophenyl]ethyl}-2-(n-hydroxyimino)-3-phenylpropanamide

n-{2-[4-(3-aminopropoxy)-3,5-dibromophenyl]ethyl}-2-(n-hydroxyimino)-3-phenylpropanamide

C20H23Br2N3O3 (511.0106)